The Construction of PCV2 DNA Vaccine and Its Immune Response in Mouse
Chunli Song
2008-01-01
Abstract:【Objective】 A kind of PCV2 DNA vaccine is constructed and its immune effect is tested.【Method】 A set of eukaryotic expression elements encoding PCV2 ORF2 is inserted into the plasmid vector pMD-18T,constructed the recombinant pMD-18T-ORF2.pMD-18T-ORF2 is transformed into E.coli DH5α to increase its copies.The Balb/c mice are injected intramuscularly with the recombinant plasmid pMD-18T-ORF2 every 14 days three times totally.The control group is injected with physiological saline solution instead.【Result】 The monitoring of antibody indicates that the specific antibody to the protein encoding by PCV2 ORF2 increases within the 14 days after the first injection.But the following immune almost make no use of the level of antibody.Compared with the control group,the spleen lymphocytes proliferative ability have a little descent(P 0.01) but the NK cells activities are significantly elevated (P0.01).The percentage of the Tc lymphocytes in spleen is much higher than the control group(P0.01),but the percentage of Th and B lymphocytes have no difference between the two group(P0.05).【Conclusion】 The constructed recombinant pMD-18T-ORF2 has the corresponding immune response to the mice,and cellural immuity is more remarkable than humoral immunity.
What problem does this paper attempt to address?